Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements

References

• HR2- agriculture Improvement Act of 2018. House-Agriculture, H. Rept. 115–661; H Rept 115–1072, 12/20/2018 Became Law No: 115–334.
   Google Scholar
• Available from: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd?fbclid=IwAR0YsxJ-2NI1rJtEbu3Hy6-sP3vlE_xBDrSe6yfoueKNtI3KIqYiTHlv6AQ#legaltosell. Accessed 327, 2020.
   Google Scholar
• S.784 Dietary Supplement Health and Education Act 1994, Senate -Labor and Human Resouces Committee- Energy and Commerce, S. Rept 103–410; 10/25/1994 Became Public Law No: 103–417.
   Google Scholar
• Kogan LR, Hellyer PW, Robinson NG. Consumers perceptions of hemp products for animals. Amer Hol Vet Med Assoc J. 2016;42:41–48.
   Google Scholar
• Kogan LR, Hellyer PW, Silcox S, Schoenfeld-Tacher R. Canadian dog owners’ use and perceptions of cannabis products. Can Vet J. 2019;60:749–755.31281193
   PubMedGoogle Scholar
• Izzo AA, Borrelli F, Capasso R, DiMarzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharma Sci. 2009;30:515–527. doi:10.1016/j.tips.2009.07.006
   PubMed Web of Science ®Google Scholar
• White CM. A review of human studies assessing cannabidiol’s therapeutic actions and potential. J Clin Pharm.2019;59:1–31. doi:10.1002/jcph.1387
   Google Scholar
• Landa L, Sulcova A, Gbelec P. The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review. Vet Med. 2016;61:111–122. doi:10.17221/8762-VETMED
   Google Scholar
• Mastinu A, Ribaudo G, Ongaro A, Bonini SA, Memo M, Gianoncielli A. Critical Review on the Chemical Aspects of Cannabidiol (CBD) and Harmonization of Computational Bioactivity Data. Curr Med Chem. 2020. doi:10.2174/0929867327666200210144847
   Google Scholar
• Premoli M, Aria F, Bonini S, et al. Cannabidiol: recent advanced and new insights for neuropsychiatric disorders treatment. Life Sci. 2019;224:120–127. doi:10.1016/j.lfs.2019.03.05330910646
   PubMedGoogle Scholar
• Pavlovuc R, Neena G, Calvi L, et al. Quality traits of “cannabidiol oils”: cannabinoid content, terpene fingerprint and oxidation stability of European commercially available preparations. Molecules. 2018;23:1–22.
   Google Scholar
• Meng Q, Buchanan B, Zuccolo J, Poulin MM, Gabriele J, Baranowski DC. A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products. PLoS One. 2018;13:1–16. doi:10.1371/journal.pone.0196396
   Google Scholar
• Bonn-Miller MO, Loflin MJ, Thomas BF, Marcu JP, Hypke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. J Am Med Assoc. 2017;318:1708–1709. doi:10.1001/jama.2017.11909
   PubMed Web of Science ®Google Scholar
• Hazekamp A. The trouble with CBD oil. Med Cannabis Cannabin. 2018;1:65–72. doi:10.1159/000489287
   PubMedGoogle Scholar
• Łebkowska-Wieruszewska B, Stefanelli F, Chericoni S, et al. Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: an explorative study. Res Vet Sci. 2019;123:26–28. doi:10.1016/j.rvsc.2018.12.00330580232
   PubMedGoogle Scholar
• Gamble LJ, Boesch JM, Frye CW, et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Front Vet Sci. 2018;5:165. doi:10.3389/fvets.2018.0016530083539
   PubMed Web of Science ®Google Scholar
• Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018;82:178–183.30026641
   PubMed Web of Science ®Google Scholar
• McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc. 2019;254:1301–1308. doi:10.2460/javma.254.11.130131067185
   PubMedGoogle Scholar
• Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals. 2019;9. doi:10.3390/ani9100832
   Google Scholar
• Citti C, Pacchetti B, Vandelli MA, Forni F, Cannazza G. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J Pharm Biomed Anal. 2018;149:532–540. doi:10.1016/j.jpba.2017.11.04429182999
   PubMedGoogle Scholar
• Hine B, Toreelio M, Gershon S. Analgesic, heart rate, and temperature effects of delta8-THC during acute and chronic administration to conscious rats. Pharmacology. 1977;15:63–72. doi:10.1159/00013666414347
   PubMedGoogle Scholar
• Wang M, Wang YH, Avula B, et al. Decarboxylation study of acidic cannabinoids: a novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry.cannabis. Cannabinoid Res. 2016;1:262–271. doi:10.1089/can.2016.0020
   PubMedGoogle Scholar
• Rock EM, Limebeer CL, Parker LA. Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain. Psychopharmacol (Berl). 2018;235:3259–3271. doi:10.1007/s00213-018-5034-1
   PubMedGoogle Scholar
• Takeda S, Misawa K, Yamamoto I, Watanabe K. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metab Dispos. 2008;36:1917–1921. doi:10.1124/dmd.108.02090918556441
   PubMedGoogle Scholar
• Eichler M, Spinedi L, Unfer-Grauwiler S, et al. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects. Planta Med. 2012;78:686–691. doi:10.1055/s-0031-129833422411724
   PubMedGoogle Scholar
• USDA Hemp Testing Guidelines. Available from: https://www.ams.usda.gov/rules-regulations/hemp/information-laboratories.
   Google Scholar
• The Massachusetts Department of Agricultural Resources (MDAR), Hemp program; M.G.L.c. 128 Section 116–123 in Massachusetts.
   Google Scholar
• Richins RD, Rodriguez-Uribe L, Lowe K, Ferral R, O’Connell MA. Accumulation of bioactive metabolites in cultivated medical cannabis. PLoS One. 2018;13(7)):e0201119Jul 23 eCollection 2018. doi:10.1371/journal.pone.020111930036388
   PubMedGoogle Scholar
• Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science. Headache. 2018;58:1139–1186. doi:10.1111/head.1334530152161
   PubMed Web of Science ®Google Scholar
• Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: no “strain,” no gain. Front Plant Sci. 2019;9:1969. doi:10.3389/fpls.2018.0196930687364
   PubMed Web of Science ®Google Scholar
• Huntsman RJ, Tang-Wai R, Alcorn J, et al. Dosage related efficacy and tolerability of cannabidiol in children with treatment-resistant epileptic encephalopathy: preliminary results of the CARE-E study. Front Neurol. 2019;10:716. doi:10.3389/fneur.2019.0071631333569
   PubMedGoogle Scholar
• Pamplona FA, da Silva LR, AC C. Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis. Front Neurol. 2018;9:759. doi:10.3389/fneur.2018.0075930258398
   PubMed Web of Science ®Google Scholar
• Craven CB, Wawryk N, Jiang P, Liu Z, Li XF. Pesticides and trace elements in cannabis: analytical and environmental challenges and opportunities. J Environ Sci. 2019;85:82–93. doi:10.1016/j.jes.2019.04.028
   Google Scholar
• Linger P, Mussig J, Fischer H, Kobert J. Industrial hemp (Cannabis sativa L.) growing on heavy metal contaminated soil: fibre quality and phytoremediation potential. Indust Crops Prod. 2012;16:33–42. doi:10.1016/S0926-6690(02)00005-5
   Google Scholar
• Antonkiewicz J, Jasiewicz C. The use of plants accumulating heavy metals for detoxification of chemically polluted soils. Elec J Polish Agric Univers. 2002;5:1–18.
   Google Scholar
• Dryburgh LM, Bolan NS, Grof CPL, et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharm. 2018;84:2468–2476. doi:10.1111/bcp.13695
   PubMed Web of Science ®Google Scholar